About TriApex
TriApex is a company based in Nanjing (China) founded in 2008. It operates as a Professional Services, and Managed Services. TriApex offers products and services including CRO Services, Disease-Oriented R&D, and Regulatory Strategies. TriApex operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Nanjing, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Triapex Laboratories Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
China Pacific Insurance
& 21 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TriApex
TriApex offers a comprehensive portfolio of products and services, including CRO Services, Disease-Oriented R&D, and Regulatory Strategies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services are provided for drug discovery and development.
Solutions are offered for disease-specific drug research.
Guidance is provided for drug regulatory compliance.
Funding Insights of TriApex
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series C - TriApex | Valuation | Legend Capital | |
| Nov, 2021 | Amount | Seed - TriApex | Valuation | Jiangsu Ruihua Investment Holding Group , Lilly Asia Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TriApex
TriApex has secured backing from 22 investors, including venture fund and institutional investors. Prominent investors backing the company include China Pacific Insurance, Qiming Venture Partners and Howbuy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture Capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Healthcare startups are funded by HLC venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TriApex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TriApex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Triapex Comparisons
Competitors of TriApex
TriApex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services for small molecules are provided.
|
|
| domain | founded_year | HQ Location |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Generic drugs and clinical research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| domain | founded_year | HQ Location |
AI powered scientific data management and workflow automation solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Triapex
Frequently Asked Questions about TriApex
When was TriApex founded?
TriApex was founded in 2008 and raised its 1st funding round 13 years after it was founded.
Where is TriApex located?
TriApex is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Who is the current CEO of TriApex?
Zhang Xuefeng is the current CEO of TriApex.
What does TriApex do?
TriApex is established as a contract research organization specializing in disease-oriented solutions for global pharmaceutical enterprises and research institutions. Services are provided across the drug development lifecycle, including disease models, pharmacodynamics, regulatory strategies, safety assessments, and clinical trials. Focus is placed on key therapeutic areas such as ophthalmology, central nervous system disorders, and metabolic diseases. An integrated platform is offered to support non-clinical and clinical research, fostering innovation through advanced technologies like iPSCs and organoids. Collaboration with over 500 domestic and overseas partners is maintained to drive pharmaceutical RD.
Who are the top competitors of TriApex?
What products or services does TriApex offer?
TriApex offers CRO Services, Disease-Oriented R&D, and Regulatory Strategies.
Who are TriApex's investors?
TriApex has 22 investors. Key investors include China Pacific Insurance, Qiming Venture Partners, Howbuy, Legend Capital, and Honghui Fund.